Detlev Ganten

Q: What Schools Are Affiliated With Detlev Ganten

Detlev Ganten is affiliated with the following schools: Harvard University, Heidelberg University, Benjamin Franklin University, Humboldt University of Berlin, University of Cologne, University of Oxford, Wake Forest University, University of Melbourne, Medical University of Warsaw, Free University of Berlin, University of Vienna, University of Helsinki, University of Erlangen–Nuremberg, McGill University

Detlev Ganten's AcademicInfluence.com Rankings

Detlev Ganten

Medical

#196

World Rank

#292

Historical Rank

Pharmacology

#27

World Rank

#33

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Detlev Ganten Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Detlev Ganten is a specialist in pharmacology and molecular medicine and is one of the leading scientists in the field of hypertension. He founded the World Health Summit in 2009. He was Chairman of the Foundation Board of the Charité Foundation , editor of the Journal of Molecular Medicine , Chairman of the Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology as well as Chairman of the Board of Trustees of the Ethnological Museum Dahlem of the Prussian Cultural Heritage Foundation.

(See a Problem?)

Detlev Ganten's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genome sequence of the Brown Norway rat yields insights into mammalian evolution (2004) (2053)
Atrial natriuretic factor—a circulating hormone stimulated by volume loading (1985) (1274)
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene (1990) (940)
Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat (1991) (738)
Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. (1985) (667)
Morphology, physiology, and molecular biology of renin secretion. (1990) (616)
Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats (1991) (614)
The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. (1991) (430)
Angiotensin and cell growth: a link to cardiovascular hypertrophy? (1991) (417)
NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats (2000) (375)
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. (1989) (374)
Rat gene mapping using PCR-analyzed microsatellites. (1992) (347)
Lessons from rat models of hypertension: from Goldblatt to genetic engineering. (1998) (336)
Angiotensin synthesis in the brain and increased turnover in hypertensive rats. (1983) (322)
Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning (2002) (316)
Angiotensin-Forming Enzyme in Brain Tissue (1971) (315)
Oxytocin unlike vasopressin is a stress hormone in the rat. (1983) (311)
Immunohistochemical evidence for the existence of angiotensin II-containing nerve terminals in the brain and spinal cord in the rat (1976) (304)
Renin in dog brain. (1971) (301)
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research (2001) (282)
Update on tissue renin–angiotensin systems (2008) (271)
Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. (1996) (263)
Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat (1984) (257)
Brain angiotensin: pathways and pharmacology (1988) (256)
Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease (1996) (255)
Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. (1978) (252)
Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. (1992) (232)
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. (1999) (226)
Hypertension-induced end-organ damage : A new transgenic approach to an old problem. (1999) (226)
Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. (1993) (221)
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. (1992) (211)
Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study (1993) (211)
Circadian blood pressure variation in transgenic hypertensive rats. (1993) (205)
Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. (1993) (204)
Enkephalin Effects on Blood Pressure, Heart Rate, and Baroreceptor Reflex (1980) (202)
Converting enzyme determines plasma clearance of angiotensin-(1-7). (1998) (198)
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. (2000) (197)
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. (1992) (190)
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. (2000) (185)
Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. (1999) (179)
Preventing dementia by preventing stroke: The Berlin Manifesto (2019) (176)
Evidence for an endogenous brain renin-angiotensin system. (1979) (174)
Lowering of hypertension by central saralasin in the absence of plasma renin (1977) (173)
Plasma angiotensin II: dipsogenic levels and angiotensin-generating capacity of renin. (1980) (173)
Differential distribution of immunoreactive angiotensin and angiotensin-converting enzyme in rat brain (1982) (168)
The brain renin-angiotensin system: a model for the synthesis of peptides in the brain. (1978) (165)
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. (2000) (165)
Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. (1990) (162)
Experimental and genetic models of hypertension (1984) (157)
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats (1994) (153)
Evidence for the presence of enkephalins in the heart. (1983) (153)
Persistent Tissue Converting Enzyme Inhibition Following Chronic Treatment with Hoe498 and MK421 in Spontaneously Hypertensive Rats (1985) (152)
Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. (1981) (151)
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. (1997) (148)
Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. (1989) (148)
Is Tissue Converting Enzyme Inhibition a Determinant of the Antihypertensive Efficacy of Converting Enzyme Inhibitors? Studies with the Two Different Compounds, Hoe498 and MK421, in Spontaneously Hypertensive Rats (1984) (148)
High human renin hypertension in transgenic rats. (1997) (146)
Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissues (1995) (146)
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. (1996) (143)
Blood pressure-independent effects in rats with human renin and angiotensinogen genes. (2000) (142)
Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. (1981) (140)
THE ISO‐RENIN ANGIOTENSIN SYSTEMS IN EXTRARENAL TISSUE (1976) (140)
Functional Annotation of Mouse Genome Sequences (2001) (136)
Emergence and evolution of the renin–angiotensin–aldosterone system (2012) (136)
Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. (1995) (134)
Atrial natriuretic peptide: a new factor in blood pressure control. (1987) (133)
Tissue renin-angiotensin systems. Their role in cardiovascular disease. (1993) (132)
Chymase-dependent angiotensin II forming systems in humans. (1996) (132)
Iso-renin of extrarenal origin. "The tissue angiotensinogenase systems". (1976) (129)
Intracardiac generation of angiotensin and its physiologic role (1988) (128)
Gluco‐ and mineralocorticoid receptor‐mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat (2000) (128)
Effects of lesions in the paraventricular nucleus of the hypothalamus on vasopressin and oxytocin contents in brainstem and spinal cord of rat (1983) (125)
Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes (2001) (124)
Local angiotensin II generation in the rat heart: role of renin uptake. (1998) (123)
Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of angiotensin II. (1980) (122)
Effects of central and peripheral angiotensin blockade in hypertensive rats. (1978) (122)
The distribution of angiotensin II-immunoreactive cells and fibers in the paraventriculo-hypophysial system of the rat (1985) (120)
Encyclopedic reference of genomics and proteomics in molecular medicine (2006) (119)
Role of Tissue Renin in the Pathophysiology of Hypertension in TGR(mREN2)27 Rats (1992) (118)
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. (2003) (118)
The renin-angiotensin-aldosterone system (2005) (112)
Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene (2000) (111)
Angiotensin‐Induced Hypertension in the Rat Sympathetic Nerve Activity and Prostaglandins (1989) (110)
Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. (1993) (108)
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. (1985) (107)
Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in Transgenic Rats Deficient in Brain Angiotensinogen (2004) (107)
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. (2000) (107)
Differential Effects of Central Angiotensin II and Substance P on Sympathetic Nerve Activity in Conscious Rats Implications for Cardiovascular Adaptation to Behavioral Responses (1985) (106)
Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin–angiotensin-system gene expression and cardiovascular functions (1995) (104)
Renal disease and the development of hypertension in salt-sensitive Dahl rats. (1988) (104)
Consensus document on non-invasive ambulatory blood pressure monitoring. The Scientific Committee. (1990) (101)
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. (2000) (101)
Brain angiotensin: on the way to becoming a well-studied neuropeptide system. (1984) (100)
Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. (1995) (99)
Renin-like immunocytochemical activity in the rat and mouse brain (1980) (98)
The renin-angiotensin system in the brain: an update 1993 (1993) (98)
The supraoptic nucleus: Afferents from areas involved in control of body fluid homeostasis (1989) (98)
Aspirin inhibits NF‐κB and protects from angiotensin II‐induced organ damage (2001) (96)
Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. (2000) (95)
Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene. (1996) (95)
The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. (1992) (95)
Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. (1996) (95)
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. (1994) (93)
The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. (2000) (93)
The Renin-Angiotensin-System in the Brain (1982) (93)
The brain renin-angiotensin system: localization and general significance. (1992) (92)
Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. (1996) (91)
Evidence of Renin Release or Production in Splanchnic Territory (1970) (89)
Release and regulation of atrial natriuretic peptide (ANP). (1987) (88)
Widespread tissue distribution of human chymase. (1994) (88)
Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen (2001) (87)
The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain (1992) (87)
Substance P Induces a Cardiovascular Defense Reaction in the Rat: Pharmacological Characterization (1988) (86)
Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. (1995) (86)
A micromethod for the measurement of renin in brain nuclei: Its application in spontaneously hypertensive rats (1982) (85)
Endogenous tissue renin-angiotensin systems. From molecular biology to therapy. (1988) (84)
Dissection of a quantitative trait locus for genetic hypertension on rat chromosome 10. (1995) (83)
Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones. (1992) (83)
Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. (1994) (82)
Dual pathway for angiotensin II formation in human internal mammary arteries (1998) (82)
The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. (1996) (81)
Plasma angiotensin II concentrations and experimentally induced thirst. (1981) (81)
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats (2001) (81)
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. (2000) (80)
Identification of Hypertension-Related Genes Through an Integrated Genomic-Transcriptomic Approach (2005) (80)
Dual peroxidase and colloidal gold-labeling study of angiotensin converting enzyme and angiotensin-like immunoreactivity in the rat subfornical organ (1986) (79)
Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats. (1996) (79)
Salt susceptibility maps to chromosomes 1 and 17 with sex specificity in the Sabra rat model of hypertension. (1998) (79)
Regulation of renin: new evidence from cultured cells and genetically modified mice (2000) (79)
Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells (1979) (78)
Antihypertensive Action of the Converting Enzyme Inhibitor Perindopril (S9490-3) in Spontaneously Hypertensive Rats: Comparison with Enalapril (MK421) and Ramipril (HOE498) (1986) (77)
Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine. (1993) (77)
Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. (1986) (76)
Antihypertensive Effect of the GABA Receptor Agonist Muscimol in Spontaneously Hypertensive Rats: Role of the Sympathoadrenal Axis (1984) (76)
Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization (1990) (75)
Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats. (1989) (74)
The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and bay K8644 and inhibited by 8-bromo-cyclicGMP (1986) (73)
Effects of [D‐Ala2]‐Methionine‐Enkephalin on Blood Pressure, Heart Rate, and Baroreceptor Reflex Sensitivity in Conscious Cats (1981) (72)
Congenic substitution mapping excludes Sa as a candidate gene locus for a blood pressure quantitative trait locus on rat chromosome 1. (1999) (71)
Minireview: The Brain Renin Angiotensin System 1982 (1982) (71)
DNA fingerprinting of spontaneously hypertensive and Wistar-Kyoto rats: implications for hypertension research. (1989) (69)
Angiotensin formation in the isolated rat hindlimb. (1989) (69)
The intrinsic brain iso-renin--angiotensin system in the rat: its possible role in central mechanisms of blood pressure regulation. (1975) (69)
Sexual dimorphism of blood pressure: Possible role of the renin-angiotensin system (1991) (68)
Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. (1984) (68)
Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. (1995) (68)
Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. (1993) (68)
Cardiac renin-angiotensin system. (1989) (68)
The cardiovascular effects of oxytocin in conscious male rats. (1985) (68)
Converting-enzyme in the choroid plexus, brain, and kidney: Immunocytochemical and biochemical studies in rats (1981) (67)
Angiotensin stimulates oxytocin release. (1981) (67)
Fast and widespread increase of basic fibroblast growth factor messenger RNA and protein in the forebrain after kainate-induced seizures (1993) (67)
The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall. (1983) (66)
Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. (1993) (66)
Molecular structure and expression of rat bradykinin B2 receptor gene. Evidence for alternative splicing. (1994) (65)
Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. (1982) (65)
Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy (2001) (65)
Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. (1979) (65)
Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. (2005) (64)
Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin. (1983) (64)
A SNP Map of the Rat Genome Generated from cDNA Sequences (2004) (64)
Structural alterations of the renin gene in stroke-prone spontaneously hypertensive rats: examination of genotype-phenotype correlations. (1990) (64)
Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay. (1988) (64)
Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats. (2000) (64)
Combined high-performance liquid chromatography-radioimmunoassay for the characterization and quantitative measurement of neuropeptides. (1984) (63)
Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. (1994) (63)
Endogenous brain angiotensin II disrupts passive avoidance behavior in rats (1979) (62)
Glucocorticoid- and estrogen-responsive elements in the 5'-flanking region of the rat angiotensinogen gene. (1991) (62)
Renin gene expression in rat tissues: a new quantitative assay method for rat renin mRNA using synthetic cRNA. (1988) (62)
Comparison between PMSG‐ and FSH‐induced superovulation for the generation of transgenic rats (2002) (62)
Tissue angiotensin II system in the human heart. (1994) (62)
Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. (2003) (61)
Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. (1994) (60)
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. (2007) (60)
Plasma atrial natriuretic peptide values in cardiac disease. (1986) (60)
The tissue renin-angiotensin systems in cardiovascular disease. (1992) (60)
Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. (1986) (60)
Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. (1988) (60)
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. (2010) (59)
Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN). (2001) (59)
It's renin in the brain: transgenic animals elucidate the brain renin angiotensin system. (2002) (58)
Differences in rat kidney morphology between males, females and testosterone-treated females. (1991) (57)
Measurement and characterization of angiotensin peptides in plasma. (1988) (56)
Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27. (1994) (55)
The brain renin-angiotensin system: molecular mechanisms of cell to cell interactions. (1995) (55)
Androgen dependence and tissue specificity of renin messenger RNA expression in mice. (1990) (55)
Vasopressin in brain of spontaneously hypertensive rats. (1982) (55)
An Ultrastructural Analysis of the Distribution of Angiotensin II in the Rat Brain (1989) (55)
Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain. (1998) (54)
Effects of enkephalins on arterial blood pressure are reduced by propranolol. (1978) (54)
Responses to Central Na+ and Ouabain Are Attenuated in Transgenic Rats Deficient in Brain Angiotensinogen (2001) (54)
Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. (1990) (54)
Transgenic rats: new experimental models for the study of candidate genes in hypertension research. (1994) (54)
Opioid peptides and blood pressure regulation. (1982) (53)
Influence of sodium, potassium, and pituitary hormones on iso-renin in rat adrenal glands. (1974) (53)
Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. (1985) (53)
Role of the α-, β-, and γ-Subunits of Epithelial Sodium Channel in a Model of Polygenic Hypertension (1997) (53)
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. (2001) (52)
Pressor action of centrally perfused angiotensin II in rats with hereditary hypothalamic diabetes insipidus. (1976) (52)
Development, genotype and phenotype of a new colony of the Sabra hypertension prone (SBH/y) and resistant (SBN/y) rat model of salt sensitivity and resistance (1996) (52)
Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. (1994) (52)
Impermeability of the blood-cerebrospinal fluid barrier for angiotensin II in rats. (1976) (52)
Lipoic acid supplementation prevents angiotensin II-induced renal injury. (2003) (50)
Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10. (2003) (50)
Catecholamine turnover changes in hypothalamus and dorsal midline area of the caudal medulla oblongata of spontaneously hypertensive rats (1979) (50)
Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats. (1995) (50)
Angiotensin-(1-7) and Baroreflex Function in Nucleus Tractus Solitarii of (mRen2)27 Transgenic Rats (2008) (49)
Studies on neuropeptide-Y catecholamine interactions in central cardiovascular regulation in the alpha-chloralose anaesthetized rat. Evidence for a possible new way of activating the alpha-2 adrenergic transmission line. (1984) (49)
Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats. (1979) (49)
Isoproterenol-induced thirst: renal and extrarenal mechanisms. (1981) (48)
Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. (1984) (48)
High levels of human chymase expression in the pineal and pituitary glands (1997) (48)
Transgenic Animals in Cardiovascular Disease Research (2000) (47)
Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. (1994) (47)
Localization of angiotensin II AT1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata (1997) (47)
Evolutionary molecular medicine (2012) (47)
Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. (1996) (47)
Hypertensive mechanisms : the spontaneously hypertensive rat as a model to study human hypertension (1982) (47)
Prevention of Cardiac Remodeling After Myocardial Infarction in Transgenic Rats Deficient in Brain Angiotensinogen (2004) (47)
Renin activity in brain tissue of puppies and adult dogs. (1971) (47)
Chronic hypertension changes myosin isoenzyme pattern and decreases myosin phosphorylation in the rat heart. (1988) (47)
Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats (1991) (46)
The semi-quantitative distribution and cellular localization of angiotensinogen mRNA in the rat brain (1992) (46)
Cellular localization of angiotensin type 1 receptor and angiotensinogen mRNAs in the subfornical organ of the rat brain (1993) (46)
Reduced content of vasopressin in the brain of spontaneously hypertensive as compared to normotensive rats (1981) (46)
Cellular expression of angiotensin type-1 receptor mRNA in the kidney. (1993) (46)
Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical complex phenotypes in human and rat hypertension. (1995) (45)
Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isoenzyme pattern of spontaneously hypertensive rats. (1988) (45)
Integrated and sequence-ordered BAC- and YAC-based physical maps for the rat genome. (2004) (45)
Effects of Enalaprilat on Circadian Profiles in Blood Pressure and Heart Rate of Spontaneously and Transgenic Hypertensive Rats (1994) (45)
Central peptidergic stimulation in blood pressure control: role of enkephalins in rats. (1981) (45)
Differential Modulation of the Baroreceptor Reflex by Brain and Plasma Vasopressin (1986) (45)
Genetic variation in hypertensive and 'control' strains. What are we controlling for anyway? (1992) (45)
Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation. (2000) (44)
Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats. (1996) (44)
Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA (1993) (44)
Congenic strains confirm the presence of salt-sensitivity QTLs on chromosome 1 in the Sabra rat model of hypertension. (2003) (44)
A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. (2007) (44)
Effect of hemorrhagic shock on the concomitant release of endorphin and enkephalin-like peptides from the pituitary and adrenal gland in the dog. (1982) (43)
Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats (1995) (43)
Atrial natriuretic factor determinations and chronic sodium homeostasis. (1986) (43)
Local renin-angiotensin system in the pineal gland. (1998) (43)
Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis (2002) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Thirst and the renin-angiotensin system. (1987) (41)
Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes. (1999) (40)
Biological and immunological properties of the nerve growth factor from bovine seminal plasma: Comparison with the properties of mouse nerve growth factor (1983) (39)
Definite Evidence for the Presence of [Ile5]-Angiotensin I and [Ile5]-Angiotensin II in the Brain of Rats (1982) (39)
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. (1987) (39)
Health co-benefits of policies to tackle climate change (2010) (39)
Renal function in hypertensive rats transgenic for mouse renin gene. (1994) (39)
Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. (1992) (38)
Pre- and postsynaptic features of the central angiotensin systems. Indications for a role of angiotensin peptides in volume transmission and for interactions with central monoamine neurons. (1988) (38)
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats. (2009) (38)
Role of kinins and substance p in the central blood pressure regulation of normotensive and spontaneously hypertensive rats (1981) (38)
Baroreceptor reflex regulation in anesthetized transgenic rats with low glia-derived angiotensinogen. (2007) (38)
Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade (2004) (38)
Human renin-dependent hypertension in rats transgenic for human angiotensinogen. (1996) (37)
Role of chromosome X in the Sabra rat model of salt-sensitive hypertension. (1999) (37)
Evidence for primary genetic determination of heart rate regulation: chromosomal mapping of a genetic locus in the rat. (1997) (36)
Central Cardiovascular Control (1983) (36)
Local renin-angiotensin systems in cardiovascular tissues: localization and functional role. (1995) (36)
Role of area postrema in transgene hypertension. (1996) (36)
Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. (1999) (35)
NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata. (1998) (35)
Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril. (1981) (35)
Mechanisms of angiotensin II formation in humans. (1995) (35)
Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen. (2001) (35)
Adrenal, kidney, and heart angiotensins in female murine ren-2 transfected hypertensive rats (1998) (34)
In vitro formation of tetraploid rat blastocysts after fusion of two‐cell embryos (2002) (34)
Transgenic animals: new approaches to hypertension research. (1990) (34)
Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. (1998) (33)
Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats (1998) (33)
Development of a New Strain of Spontaneously Hypertensive Rats Homozygous for Hypothalamic Diabetes Insipidus (1983) (33)
The cardiac renin-angiotensin system: a synopsis of current experimental and clinical data. (1991) (32)
Inhibition of drinking in water-deprived rats by combined central angiotensin II and cholinergic receptor blockade. (1978) (32)
Modulation of Reflex Function by Endogenous Angiotensins in Older Transgenic Rats With Low Glial Angiotensinogen (2008) (32)
Evidence against co-storage of enkephalins with noradrenaline in bovine adrenal medullary granules. (1982) (32)
Brain angiotensin II stimulates release of pituitary hormones, plasma catecholamines and increases blood pressure in dogs. (1980) (32)
Development of Parthenogenetic Rat Embryos1 (2003) (32)
Transgenic animals as models for human disease. (1995) (32)
Mechanisms of angiotensin H formation in humans (1995) (32)
Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. (1993) (31)
2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. (1984) (31)
In vivo activity of purified mouse brain renin (1981) (31)
Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts. (1984) (31)
Characterization of rat intestinal angiotensin II receptors. (1991) (31)
Evidence for the existence of angiotensin II like immunoreactivity in subpopulations of tyrosine hydroxylase immunoreactive neurons in the A1 and C1 area of the ventral medulla of the male rat (1990) (31)
Alternative splicing of the mRNA coding for the human endothelial angiotensin-converting enzyme: a new mechanism for solubilization. (1998) (30)
Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases. (1996) (30)
Immunocytochemical Demonstration of Angiotensin II and Renin-Like Immunoreactive Nerve Cells in the Hypothalamus. Angiotensin Peptides as Comodulators in Vasopressin and Oxytocin Neurons and Their Regulation of Various Types of Central Catecholamine Nerve Terminal Systems (1982) (29)
Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats. (1998) (29)
Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers. (1987) (29)
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats. (1982) (29)
Detection of vasopressin mRNA in the neurointermediate lobe of the rat pituitary. (1990) (29)
Angiotensin stimulates β-endorphin release from anterior pituitary gland cell cultures of rats (1984) (29)
Angiotensinogen gene expression in extrahepatic rat tissues: Application of a solution hybridization assay (1988) (28)
Blockade of Endothelin Receptors Attenuates End-Organ Damage in Homozygous Hypertensive Ren-2 Transgenic Rats (2004) (28)
Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? (1985) (28)
Coexistence of renin and angiotensin II in epitheloid cell secretory granules of rat kidney (2004) (28)
Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen (2000) (28)
The brain renin--angiotensin system. (1981) (28)
Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release. (1997) (28)
Converting enzyme inhibitors: antihypertensive drugs with unexpected mechanisms (1983) (27)
Angiotensin I converting enzyme and chymase in cardiovascular tissues. (1996) (27)
Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. (1994) (27)
Mechanism by Which Angiotensin II Stabilizes Messenger RNA for Angiotensinogen (1994) (27)
Arterial and Urinary Renin Activity (1972) (27)
Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat. (1996) (27)
Atrial natriuretic factor in sodium-sensitive and sodium-resistant Dahl rats. (1987) (26)
Localization of renin (EC 3.4.23) and converting enzyme (EC 3.4.15.1) in nerve endings of rat brain (1985) (26)
Adrenal Actions on Brain (1982) (26)
Is arterial media hypertrophy in spontaneously hypertensive rats a consequence of or a cause for hypertension? (1980) (26)
Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. (1992) (26)
The intrarenal renin-angiotensin-system (1982) (26)
Pharmacology of Antihypertensive Therapeutics (1990) (26)
Evidence for a selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata of young spontaneous hypertensive rats. (1979) (26)
Vasopressin in Deoxycorticosterone Acetate Hypertension of Rats: A Hemodynamic Analysis (1983) (26)
Relationship between renin mRNA and renin secretion in adrenalectomized, salt-depleted, or converting enzyme inhibitor-treated rats (1987) (26)
Mild hypertension : from drug trials to practice (1987) (26)
Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. (1995) (25)
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. (1986) (25)
Mechanisms Controlling Release of Atrial Natriuretic Peptide (1987) (25)
The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and Bay K8644 and inhibited by 8-bromo-cyclic GMP. (1986) (25)
Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. (1998) (25)
Pharmacology of converting enzyme inhibitors: new aspects. (1983) (25)
Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features. (1997) (25)
Molecular genetics of hypertension. (1992) (24)
Evidence for differential localization of angiotensin-I converting enzyme and renin in the corpus striatum of rat. (1980) (24)
Blood pressure and heart rate responses to centrally administered substance P are increased in spontaneously hypertensive rats. (1980) (24)
On the plasticity of the cerebellar renin-angiotensin system: localization of components and effects of mechanical perturbation (1994) (24)
The renin-angiotensin system in the brain. Localization and functional significance. (1993) (24)
Vasopressin mRNA in the neurolobe of the rat pituitary (1990) (24)
Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging (2006) (24)
Evidence for local angiotensin formation in brain of nephrectomized rats (1976) (24)
Pressure-natriuresis and -diuresis in transgenic rats harboring both human renin and human angiotensinogen genes. (1998) (24)
Increased vasopressor actions of intraventricular neuropeptide Y-(13–36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius (1995) (23)
The Role of Wnk4 in Polygenic Hypertension: A Candidate Gene Analysis on Rat Chromosome 10 (2003) (23)
Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids. (1988) (23)
Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex. (1981) (23)
Salt-sensitive hypertension in (mREN-2)27 transgenic rats. (1996) (23)
Nomenclature for atrial peptides. (1987) (23)
Differential regulation of vascular angiotensin I-converting enzyme in hypertension. (1994) (23)
Peptidergic systems: effects on blood vessels. (1984) (23)
Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats. (1997) (22)
Transcriptional regulatory elements in the rat bradykinin B2 receptor gene. (1996) (22)
The adrenal cortex and essential hypertension. (1976) (22)
Angiotensinogen is cleaved to angiotensin in isolated rat blood vessels. (1993) (22)
Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats. (1997) (22)
Unlike human hypertension, blood pressure in a hereditary hypertensive rat strain shows no linkage to the angiotensinogen locus. (1994) (22)
Differential Actions of Neuronal and Hormonal Vasopressin on Blood Pressure and Baroreceptor Reflex Sensitivity in Rats (1986) (22)
Sympathetic activation following central vasopressin receptor stimulation in conscious rats. (1984) (22)
Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. (1994) (22)
Improved immunohistochemical staining of angiotensin II in rat brain using affinity purified antibodies (1987) (22)
Effect of urapidil, clonidine, and prazosin on sympathetic tone in conscious rats. (1986) (21)
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. (2004) (21)
Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene. (1996) (21)
Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats. (1994) (21)
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. (1990) (21)
Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the rat. (1995) (21)
Transcriptional regulation of the rat renin gene by regulatory elements in intron I. (1999) (21)
Is there a brain isorenin-angiotension system? (1978) (20)
Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats (1996) (20)
Neurobiology of Oxytocin (1986) (20)
The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulation. (1985) (20)
Intraventricular injections of renin increase amine turnover in the tuberoinfundibular dopamine neurons and reduce the secretion of prolactin in the male rat. (1982) (20)
Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen (2004) (20)
Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role? (1992) (19)
The Tissue Angiotensinogenase Systems (1978) (19)
The localization of converting enzyme in kidney vessels of the rat (2004) (19)
Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats. (2008) (19)
Brain Peptides and Blood Pressure Regulation (1982) (19)
Peptidergic control of cardiovascular function: the angiotensin paradigm. (1990) (19)
Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats. A study on cause and effect. (1995) (19)
Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat (1993) (19)
The brain angiotensin system: subcellular localization and interferences with converting enzyme inhibitors. (1983) (18)
Angiotensinogen messenger RNA stabilization by angiotensin II. (1996) (18)
Neuropeptides and Central Blood Pressure Regulation (1983) (18)
High-throughput scanning of the rat genome using interspersed repetitive sequence-PCR markers. (2000) (18)
The Renin and Iso-Renin-Angiotensin Systems in Rats with Experimental Pituitary Tumors (1975) (18)
Subcellular Localization of Cerebral Renin-Like Activity (1972) (18)
Plasma and kidney angiotensin II levels and renal functional responses to AT1 receptor blockade in hypertensive Ren-2 transgenic rats (2004) (18)
The renin and isorenin-angiotensin system in rats with hereditary hypothalamic diabetes insipidus (1978) (18)
Membrane microviscosity does not correlate with blood pressure: a cosegregation study (1993) (17)
Increase of basic fibroblast growth factor (bFGF, FGF-2) messenger RNA and protein following implantation of a microdialysis probe into rat hippocampus (2004) (17)
Mechanisms of cardiac growth. The role of the renin-angiotensin system. (1992) (17)
Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats. (2002) (17)
Cardiac angiotensin II receptors: studies on functional coupling in Sprague-Dawley rats and TGR(alphaMHC-hAT1) transgenic rats. (1997) (17)
Presence of renin-like immunoreactivity in oxytocin immunoreactive nerve cells of the paraventricular and supraoptic nuclei in the rat hypothalamus. (1982) (17)
Efficiency of transgenic rat production is independent of transgene-construct and overnight embryo culture. (2004) (17)
An Intrinsic Renin-Angiotensin System in the Brain (1972) (17)
The transmitters of the hypothalamus (1978) (17)
Permanent inhibition of angiotensinogen synthesis by antisense RNA expression. (1996) (17)
Aspects of molecular biology and biochemistry of the cardiac renin-angiotensin system. (1989) (17)
Morphometric evaluation of the coexistence of renin-like and oxytocin-like immunoreactivity in nerve cells of the paraventricular hypothalamic nucleus of the rat (1982) (17)
THE ROLE OF CENTRAL CATECHOLAMINE PATHWAYS IN SPONTANEOUS AND RENAL HYPERTENSION IN RATS (1980) (16)
Evidence for a differential modulation of the alpha-2 adrenoceptors by angiotensin II in the nucleus tractus solitarii of the spontaneously hypertensive and the Wistar-Kyoto normotensive rats (1995) (16)
Iso-renin, electrolytes and catecholamines in dog brain: possible interrelationship. (1973) (16)
Das estnische Genomprojekt im Kontext der europäischen Genomforschung (2004) (16)
Acute sino-aortic denervation in rats produces a selective increase of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and a reduction of adrenaline levels in the anterior and posterior hypothalamus. (1981) (16)
Effect of losartan on right ventricular hypertrophy and cardiac angiotensin I-converting enzyme activity in pulmonary hypertensive rats. (1996) (16)
Increased potency of neuropeptide y to antagonize α 2-adrenoceptor function in the nucleus tractus solitarii of the spontaneously hypertensive rat (1997) (16)
Genetics of Primary Hypertension (1994) (16)
Conserved synteny in rat and mouse for a blood pressure QTL on human chromosome 17. (2002) (16)
Report of the Joint Nomenclature and Standardization Committee of the International Society of Hypertension, American Heart Association and the World Health Organization (1987) (16)
Dose effects of human renin in rats transgenic for human angiotensinogen. (1997) (16)
[The Estonian Genome Project in the context of European genome research]. (2004) (16)
Immunohistochemistry of the renin-angiotensin-system in the kidney. (1983) (16)
Neurobiology of Vasopressin (1985) (16)
Grundlagen der Molekularen Medizin (2003) (15)
Alterations in Sympathetic Ganglionic Transmission in Response to Angiotensin II in (mRen2)27 Transgenic Rats (2004) (15)
Release of opioid peptides in canine hemorrhagic hypotension: Effects of naloxone (1984) (15)
Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. (1996) (15)
Modulation of blood pressure and the renin‐angiotensin system in transgenic and spontaneously hypertensive rats after ovariectomy (1993) (15)
Role of the alpha-, beta-, and gamma-subunits of epithelial sodium channel in a model of polygenic hypertension. (1997) (15)
Thirst in the rat after ligation of the inferior vena cava: Role of angiotensin II (1981) (15)
Central Nervous System Control of the Heart (1986) (15)
Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats. (1982) (15)
Changes of blood pressure and aortic strip contractile responses to ET-1 of heterozygous female transgenic rats, TGR(mRen2)27. (1998) (15)
Effect of estrogen on neprilysin expression in uterus and kidney of Sprague–Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats (2006) (15)
Hearing loss: a global health issue (2015) (15)
Insulin resistance and hypertension: studies in transgenic hypertensive TGR(mREN-2)27 rats. (1994) (15)
The Role of the Renin-Angiotensin System in Cardiovascular Disease (1994) (14)
Sleep, clinical and experimental aspects (1982) (14)
Rodent models for studying steroids and hypertension: From fetal development to cells in culture (1995) (14)
Kinin-forming activity in rat brain (1985) (14)
Blood pressure, electrolyte and adrenal responses in swim-trained hypertensive rats. (1987) (14)
Evidence for the existence of angiotensinogen mRNA in magnocellular paraventricular hypothalamic neurons. (1988) (14)
Molecular biology and biochemistry of the renin-angiotensin system (1994) (14)
Roles of Nitric Oxide and Oxidative Stress in the Regulation of Blood Pressure and Renal Function in Prehypertensive Ren-2 Transgenic Rats (2005) (14)
Role of central AT1 and V1 receptors in cardiovascular adaptation to hemorrhage in SD and renin TGR rats. (1999) (14)
Extra-hepatic transcription of plasma prekallikrein gene in human and rat tissues. (1993) (14)
Atrial natriuretic peptides in brain nuclei of rats with inherited diabetes insipidus (Brattleboro rats). (1990) (13)
ON THE ORIGIN OF ANGIOTENSIN-LIKE PEPTIDES IN CEREBROSPINAL FLUID (1977) (13)
Depressor role of angiotensin AT2 receptors in the (mRen-2)27 transgenic rat. (1998) (13)
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27. (1994) (13)
Tissue renin-angiotensin systems aspects of molecular biology and pharmacology. (1988) (13)
The brain isorenin-angiotensin system: localization and biological function. (1977) (13)
Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto. (2019) (13)
Regional expression of angiotensinogen mRNA in the brain of one-week-old, adult and old male rats. (1993) (13)
Infertility in a transgenic rat due to impairment of cytoplasmic elimination and sperm release from the Sertoli cells. (1995) (12)
Morphometrical and Microdensitometrical Studies on Monoaminergic and Peptidergic Neurons in the Aging Brain (1985) (12)
In situ hybridization demonstrates vasopressin gene transcription in hypothalamic neurons of crossbred hypertensive × diabetes insipidus rats (1988) (12)
Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats (1991) (12)
Contribution of a 12 kDa protein to the angiotensin II-induced stabilization of angiotensinogen mRNA: interaction with the 3' untranslated mRNA. (1995) (12)
Molekularmedizinische Grundlagen von fetalen und neonatalen Erkrankungen (2005) (12)
The central pressor actions of substance P are inhibited by GABA. (1986) (12)
Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27] (1997) (12)
Changes in the central ANF-system of renovascular hypertensive rats. (1991) (12)
Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene. (1999) (12)
Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27. (1998) (12)
Tissue distribution of angiotensinogen mRNA during experimental inflammation (1993) (12)
Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition. (1991) (12)
Morphology of Hypothalamus and Its Connections (1986) (12)
Neuroendocrinology of Mood (1988) (12)
Atrial natriuretic peptide and volume changes in children. (1986) (11)
Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats. (2005) (11)
Basic fibroblast growth factor expression and tenascin C immunoreactivity after partial unilateral hemitransection of the rat brain (1996) (11)
PCR analysis of human renal biopsies--renin gene regulation in glomerulonephritis. (1994) (11)
Cardiac-specific expression of the human ATI receptor in transgenic rats (1996) (11)
Stimulus-Secretion Coupling in Neuroendocrine Systems (1988) (11)
Implementing the proclamation of stroke and potentially preventable dementias (2018) (11)
Molecular Cloning and Functional Characterization of a Mouse Bradykinin B1 Receptor Gene: Volume220,Number 1 (1996), pages 219–225 (1996) (10)
[A test for assessing the responsiveness of plasma renin activity]. (1970) (10)
Renal kallikrein activity and urinary kallikrein excretion in rats with experimental renal hypertension. (1982) (10)
Vascular production and regulation of angiotensin. (1991) (10)
Measurement of mRNA by solution hybridization with 32P-labelled single stranded cRNA probe ("SP6 test"). Comparison with a 32P-labelled single stranded cDNA as hybridization probe ("S1 test") for measurement of AVP mRNA. (1988) (10)
The evolution of evolutionary molecular medicine (2012) (10)
Implementing the Proclamation of Stroke and Potentially Preventable Dementias (2018) (10)
The renin-angiotensin system and renal function in transgenic (mRen2)27 rats. (1996) (10)
Adrenal renin is released into the circulation of the hypertensive transgenic rat TGR (mRen-2)27. (1992) (10)
Plasma steroids in rats with experimental ectopic pituitary tumor and arterial hypertension. (1974) (10)
Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats. (1995) (10)
Brain peptides and blood pressure control. (1987) (10)
Human angiotensinogen is highly expressed in astrocytes in human cortical grafts (1994) (10)
Increased central angiotensin and osmotic responses in the Ren-2 transgenic rat. (1999) (10)
High blood pressure maintenance in transgenic mRen-2 vs. Lyon genetically hypertensive rats. (1993) (10)
Pathogenesis of hypertension in spontaneously hypertensive rats: definite evidence against a pressor role of vasopressin. (1984) (10)
Enalapril and renal function in hypertensive rats transgenic for mouse renin gene. (1997) (10)
Actions of Progesterone on the Brain (1985) (9)
Brain angiotensin-like localization at the ultrastructural level. (1984) (9)
Central depletion of angiotensinogen is associated with elevated AT1 receptors in the SFO and PVN (2009) (9)
Pharmacological interferences with the renin-angiotensin system. (1984) (9)
Genome-wide linkage reveals a locus for human essential ( primary ) hypertension on chromosome 12 p (2003) (9)
The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors. (1989) (9)
Cardiovascular and Humoral Effects of Endogenous Brain Angiotensin (1982) (9)
Cardiorenal consequences of dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibition in transgenic rats with an extra renin gene. (1996) (9)
Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats. (1981) (9)
Effect of High Calcium Diet on Magnesium, Catecholamines, and Blood Pressure of Stroke-Prone Spontaneously Hypertensive Rats 1 (1988) (9)
Immunsystem und Infektiologie (1999) (9)
Humoral and neurohormonal aspects of blood pressure regulation: Focus on angiotensin (2005) (9)
Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors. (1987) (9)
A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats. (1979) (9)
Emotional stress and arterial hypertension. (1982) (9)
Academic medicine must take its global role: the M8 Alliance of Academic Health Centers and Medical Universities (2010) (9)
Intracerebroventricular angiotensin II increases arterial blood pressure in rhesus monkeys by stimulation of pituitary hormones and the sympathetic nervous system (1982) (9)
Overcoming fragmentation of health research in Europe: lessons from COVID-19 (2020) (9)
Renin in heart muscle and arterial tissue. (1972) (8)
Angiotensin II Immunoreactivity in the Human Striatum and Hippocampus of Elderly Controls and Patients with Senile Dementia of the Alzheimer Type and Multi-Infarct Dementia (1991) (8)
The renin-angiotensin system in the central control of blood pressure. (1987) (8)
Tissue Distribution of Ren-2 Expression in Transgenic Rats (1991) (8)
Functional testing of components of the brain renin-angiotensin system in transgenic animals (1998) (8)
The Renin angiotensin system in the brain : a model for the synthesis of peptides in the brain (1982) (8)
Acute Effects of Cyclooxygenase-2 Inhibition on Renal Function in Heterozygous Ren-2-Transgenic Rats on Normal or Low Sodium Intake (2004) (8)
Angiotensinogen mRNA and pressor reactions to angiotensin in brain stem areas of spontaneously hypertensive rats. (1993) (8)
Tissue iso-renins. (1976) (8)
Vascular angiotensin and the sympathetic nervous system: do they interact? (1994) (8)
Distribution of neurophysins in rat brain: Radioimmunological measurement and characterization (1982) (8)
6 Differential Response of Efferent Sympathetic Nerve Activity Following Central Stimulation with Angiotensin II and Substance P in Conscious Rats (1984) (8)
The influence of cold stress on the myosin heavy chain expression of cardiac and smooth muscle in normotensive and spontaneously hypertensive female rats. (1991) (7)
Effect of intraventricular perfusion of angiotensin II in conscious normal rats and in rats with hereditary hypothalamic diabetes insipidus. (1976) (7)
Cardiovascular and renal effects of atrial natriuretic factor. (1987) (7)
Behavioral Aspects of Neuroendocrinology (1990) (7)
Innervation of the Juxtaglomerular Apparatus and the Effect of Renal Nerve Stimulation (1978) (7)
Vascular conversion of angiotensin I in stroke-prone spontaneously hypertensive and Wistar—Kyoto rats (1993) (7)
Endothelial injury in transgenic (mRen-2)27 hypertensive rats. (1997) (7)
Molecular Reviews in Cardiovascular Medicine (1996) (7)
Transcriptional silencer in intron I of the rat renin gene (1994) (7)
Reduced Synthesis of [Arginine]Vasopressin in Spontaneously Hypertensive Rats (1982) (7)
The renin-angiotensin system in transgenic rats (1996) (7)
[The renin-angiotensin system: systemic and local function]. (1988) (7)
Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat (2000) (7)
Interferences with the Renin-Angiotensin System and Their Effects on High Blood Pressure (1977) (7)
Effects of chronic sino-aortic denervation in male rats on regional catecholamine levels and turnover and on neuroendocrine function. (1983) (6)
Transcriptional silencer in intron I of the rat renin gene. (1995) (6)
Zona glomerulosa of the adrenal gland in a transgenic strain of rat: a morphologic and functional study (1994) (6)
Report from the International Society of Endocrinology (1985) (6)
Induction of hippocampal glial cells expressing basic fibroblast growth factor RNA by corticosterone (2001) (6)
Immobilization stress induces vasodepressor and altered neuroendocrine responses in the adult stroke-prone spontaneously hypertensive male rat. (1993) (6)
Role of the Brain Renin-Angiotensin System in Central Mechanisms of Blood Pressure Control (1981) (6)
Angiotensin-like activity in resistance vessels (1983) (6)
Effects of Hydrochlorothiazide on Water, Cation, and Norepinephrine Contents of Cardiovascular Tissues of Renovascular Hypertensive Dogs 1 (1974) (6)
Effects of atrial natriuretic factor in rats with renal insufficiency. (1987) (6)
The role of neuropeptides in cardiovascular regulation (1991) (6)
Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen (2001) (6)
[Angiotensin antagonists in the diagnosis and treatment of renin-dependent hypertension]. (1976) (6)
Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system. (1995) (6)
Alterations of Cardiac α- and β-Adrenoceptors and Inotropic Responsiveness in Hypertensive Transgenic Rats Harbouring the Mouse Renin Gene (TGR(mREN2)27) (1995) (6)
The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm. (1993) (5)
Chapter 5 – THE BRAIN RENIN-ANGIOTENSIN SYSTEM: BASIC AND FUNCTIONAL CONSIDERATIONS (1998) (5)
Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen (2004) (5)
Genetics of primary hypertension. (1994) (5)
Central pressor actions of angiotensin II. (1976) (5)
Enhanced blood pressure buffering role of the brain nitrergic system in renin transgenic rats (1999) (5)
Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene. (1997) (5)
Molecular cloning & functional characterization of a mouse bradykinin B1 receptor gene. (1996) (5)
Blood pressure effects of endogenous brain angiotensin in rats are increased by inhibition of prostaglandin biosynthesis. (1979) (5)
Mapping of candidate genes for hypertension by fluorescence in situ hybridization on the genome of transgenic rats and mice. (1998) (5)
Molekularmedizinische Grundlagen von haematologischen Neoplasien (2003) (5)
Identification of adrenomedullin as a candidate gene in the stroke-prone phenotype of spontaneously hypertensive rats (SHRSP) (1998) (5)
Genetic mapping in hypertension. (1992) (5)
Infertility in a transgenic rat due to impairment of cytoplasmic elimination and sperm release from the Sertoli cells. (1995) (5)
[Isolated systolic hypertension in old age]. (1993) (5)
EFFECTS OF CENTRALLY ADMINISTERED ANGIOTENSIN II AND ANGIOTENSIN II ANTAGONIST ON ARTERIAL BLOOD PRESSURE IN DIFFERENT STRAINS OF RATS (1977) (5)
The Journal of Molecular Medicine: tradition, continuity, and renaissance (2004) (5)
The brain renin angiotensin system in central cardiovascular control. (1984) (5)
Erkrankungen des Zentralnervensystems (1999) (5)
Central cardiovascular control : basic and clinical aspects (1983) (5)
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen (2006) (5)
Differential regulation of beta-endorphin in the anterior pituitary, intermediate lobe, hypothalamus and brain stem. (1983) (5)
Basic methodology in the molecular characterization of genes. (1992) (5)
Reduced Formation of Ang‐(1–7) by ACE2 in Dorsal Medulla Oblongata of Sprague‐Dawley (SD) and ASrAogen Rats During Aging (2006) (4)
Transgenic rats: tools to study the function of the renin-angiotensin system. (1996) (4)
Brain angiotensin II: localization and possible functions. (1987) (4)
IMMUNOHISTOCHEMICAL EVIDENCE FOR THE EXISTENCE OF ANGIOTENSIN II CONTAINING NERVE TERMINALS IN THE CENTRAL NERVOUS SYTEM OF THE RAT (1977) (4)
SEARCH FOR GENETIC-DETERMINANTS OF ENVIRONMENTAL SUSCEPTIBILITY IN HYPERTENSION - EFFECT OF HEAT, IMMOBILIZATION STRESS AND ENDOTOXIN (1992) (4)
Was ist der Mensch? Wer ist der Mensch? (2008) (4)
Scientific Panel for Health: better research for better health (2016) (4)
Eine einfache, empfindliche Mikromethode zur Bestimmung der Plasma-Renin-Konzentration beim Menschen (1972) (4)
What is life? On Erwin Schrödinger, his cat, and the Journal of Molecular Medicine (2007) (4)
Salt and hypertension : dietary minerals, volume homeostatis, and cardiovascular regulation (1989) (4)
Immunocytochemical Demonstration of Renin and Converting Enzyme in Rat and Mouse Brain (1982) (4)
Sexual Dimorphism of Cardiovascular Function: The Role of Androgens (1992) (4)
Assignment1 of the kinin receptor B1 and B2 genes (Bdkrb1 and Bdkrb2) to rat chromosome 6q3.2 by FISH and radiation hybrid mapping (2000) (4)
The effects of beta-adrenoreceptor blockers on blood pressure responses to central angiotensin II (1981) (4)
Renin-dependent water intake in hypovolemia (1988) (4)
110. Left ventricular hypertrophy and myocardial infarction increase left ventricular angiotensinogen gene expression (1991) (4)
[Pathophysiology of the renin-angiotensin system]. (1990) (4)
Tissue-specific regulation of gene expression for renin and angiotensinogen. (1988) (4)
Molekular- und zellbiologische Grundlagen (1997) (4)
Molekularmedizinische Grundlagen von Endokrinopathien (2001) (4)
THE TRANSGENIC RATS TGR(MREN2)27 - ROLE OF TISSUE RENIN IN THE PATHOPHYSIOLOGY OF HYPERTENSION (1991) (4)
300 Jahre Charité - im Spiegel ihrer Institute (2010) (4)
Molekularmedizinische Grundlagen von rheumatischen Erkrankungen (2003) (4)
Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats. (1998) (4)
Peptidergic and catecholaminergic mechanisms in central blood pressure control. (1980) (4)
Fostering trust—J Mol Med’s scientific integrity policy (2008) (3)
Atrial Natriuretic Factor is a Hormone (1985) (3)
Comparison of angiotensin II staining in rat brain using affinity purified and crude antisera. (1987) (3)
Role of endocrine brain in the control of hypertension angiotensin II and atrial natriuretic peptide in the brain (1992) (3)
Role of central AT1 and V1 receptors in cardiovascular adaptation to hemorrhage in SD and renin TGR rats. (1999) (3)
Salt and Hypertension (1989) (3)
Effect of denervation on the leucine-enkephalin content of the adrenal gland of spontaneously hypertensive rats (SHRSP). (1984) (3)
Angiotensin stimulates oxytocin release: imparied response in rats with genetic hypothalamic diabetes insipidus. (1982) (3)
Primary hypertension and the renin angiotensin system - from the laboratory experiment to clinical relevance (1992) (3)
The renin-angiotensin system in transgenic rats: characteristics and functional studies. (1993) (3)
Chronic Intracerebroventricular AT1 Receptor Blockade, but not Renin Inhibition, Normalizes Blood Pressure in (mRen2)27 Transgenic Rats (2008) (3)
James D. Watson at the Congress of Molecular Medicine. (1997) (3)
Angiotensin Dependent Thirst Following Polyethyleneglycol Treatment in the Rat (1986) (3)
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. (1997) (3)
The Brain-Renin-Angiotensin System: Update (1986) (3)
Proceedings: Influence of angiotensin II and angiotensin II antagonist (P 113) in vitro on cell growth in 3T3 and virus transformed SV40 3T3 cells. (1975) (3)
Building Bridges through Science (2017) (3)
Worse than pulp fiction: fraud in science (1997) (3)
Alterations of cardiac alpha- and beta-adrenoceptors and inotropic responsiveness in hypertensive transgenic rats harbouring the mouse renin gene (TGR(mREN2)27). (1995) (3)
Influence of intracerebroventricular (ICV) GTP-electrolyte infusion on ICV (D-ALA2, D-LEU5) enkephalin (DADL)-induced cardiovascular effects in rats. (1984) (3)
A View from Cognitive Science (2008) (3)
Eine merkwürdig „alte“ Antwort auf eine noch ältere Frage (2008) (3)
Transgenic Rats with Low Brain Renin-Angiotensin System Activity Due to Glial Deficiency Are Protected Against Heart Failure Late in Life (2007) (3)
Science Has to Take Responsibility. 10 Years World Health Summit—The Road to Better Health for All (2018) (3)
Interactions between brain angiotensin and prostaglandins in rats. (1984) (3)
Shaping future health: Berlin Evolution of Medicine Summit (2009) (3)
Receptor autoradiographical evidence of a preferential reduction of binding sites for atrial natriuretic factor in renal papilla of the spontaneously hypertensive rat. (1988) (3)
New tools for the high throughput characterization of rat genomic DNA samples (2000) (2)
The gene encoding endothelial nitric oxide synthase, Nos3, maps to rat Chromosome 4 (2004) (2)
48. Glucocorticoid- and estrogen-responsive elements in the 5-region of the rat angiotensinogen gene (1991) (2)
23. The transgenic mRen2 rat: cardiovascular characterization of a novel hypertensive animal model (1991) (2)
Hybridization of Renin cdna with mrna from Various Mouse Tissues and Characterization of Angiotensin Peptides (ang) In Tissue of Primates (1985) (2)
Interstrain differences in angiotensin I-converting enzyme mRNA and activity levels. Comparison between stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats. (1999) (2)
Symposium on Neuropeptides and Blood Pressure Control (1983) (2)
Report on rat chromosome 10 (1999) (2)
The stroke-prone spontaneously hypertensive rat and its role in the genetic dissection of cardiovascular disease (1997) (2)
Science to policy: M8 Alliance invites policy makers to step in (2011) (2)
The effects of orchidectomy and testosterone replacement therapy on plasma and brain oxytocin in normal rats. (1987) (2)
Expression of the mouse ren-2 gene in the small intestine is regulated by food intake (1993) (2)
Nomenclature of the renin-angiotensin system (2005) (2)
Renin-Angiotensin-System (RAS) und COVID-19 – Zur Verordnung von RAS-Blockern (2020) (2)
151 years Berliner Klinische Wochenschrift and the 20th anniversary of the Journal of Molecular Medicine (2015) (2)
[Renin-Angiotensin-System (RAS) and COVID-19 Blockers]. (2020) (2)
Molecular Biology of Tissue Renin (1989) (2)
Vasopressin gene expression in hypertensive, normotensive, and diabetes insipidus rats. (1988) (2)
Hormones, autacoids, neurotransmitters, and growth factors: editorial overview (1993) (2)
The renin-angiotensin paradigm. Practical therapeutical consequences of basic research. (1993) (2)
Monogen bedingte Erbkrankheiten 1 (2000) (2)
Proceedings: Iso-renin in adrenal glands of rats: a possible factor in steroid production. (1974) (2)
Fallstricke evolutionärer (Selbst-) Bewusstseinsmodelle (2008) (2)
Leben, Natur, Wissenschaft : alles, was man wissen muss (2003) (2)
Inhibition of the PI3 Kinase Signal Transduction Pathway in Nucleus Tractus Solitarii of (mRen2)27 Transgenic Rats improves Baroreceptor Sensitivity (2008) (2)
Zur Zukunft der molekularen Medizin (2003) (2)
Der Mensch – das sich selbst erfindende Wesen (2008) (2)
ON THE ROLE OF NORADRENALINE AND ADRENALINE NEURON SYSTEMS IN CONTROL OF CENTRAL CARDIOVASCULAR FUNCTIONS (1979) (2)
Effect of Saralasin and atropine on thirst induced by water deprivation. (1977) (2)
Genes Independent Effects in Rats With Human Renin and Angiotensinogen − Blood Pressure (2000) (2)
The Brain Renin-Angiotensin System: Problems and Answers (1984) (2)
The Human Renin-Angiotensin System in Transgenic Rats — New Tools for Antihypertensive Therapy (1993) (2)
Antihypertensive Action and Inhibition of Tissue Converting Enzyme by Three Prodrug Converting Enzyme Inhibitors, Perindopril, Ramipril and Enalapril, in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP) (1986) (2)
THE ROLE OF ADRENAL RENIN IN STEROID-METABOLISM AND DEVELOPMENT OF HYPERTENSION IN TRANSGENIC RATS TGR (MESSENGER REN2) (1992) (2)
The Central Peptidergic Stimulation Syndrome: A Role for Brain Peptides in Central Mechanisms of Blood Pressure Regulation (1980) (2)
Renin-Angiotensin-System (RAS) und COVID-19 (2020) (1)
Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension. (1983) (1)
Was ist der Mensch? Anmerkungen zu einer unwissenschaftlichen Frage (2008) (1)
Spironolactone Prevents Activation of the Intrarenal Renin-Angiotensin System and Increases Survival in (mREN2) 27 Transgenic Rats with Malignant Hypertension. (2000) (1)
Renin-angiotensin in extrarenal tissues. (1972) (1)
[The significance of molecular biology in hypertension research]. (1989) (1)
JMM and medical science, past and present (2000) (1)
Funktionen des Bewusstseins (2008) (1)
Evolutionäre Medizin - Evolution der Medizin (2009) (1)
Effects of antihypertensive treatment on Cardiac Hypertrophy and Collagen Expression in Transgenic Hypertensive Rats:TGR (mREN2) 27 (1995) (1)
Brain Peptides in Cardiovascular Regulation (1986) (1)
Regulation of myosin heavy chain (MHC) gene expression in cardiac hypertrophy: Effects of testosterone and cAMP (1992) (1)
High Blood Pressure Control in the Community (1985) (1)
Brain Converting Enzyme and Hypertension (1982) (1)
Increased blood pressure responses to central angiotensin II in spontaneously hypertensive rats (2005) (1)
In vivo enzyme activity of purified human brain renin (2005) (1)
Es kommt darauf an (2008) (1)
A13 - Development and characteristics of the sabra salt sensitive (hypertension-prone) SBH/y and salt resistant (hypertension-resistant) SBN/y rats (1995) (1)
Zehn Thesen zur „Natur des Menschen“ (2008) (1)
Unterschiedliche Wirkung zentraler und peripherer Angiotensin-II-Blockade beim genetischen Hochdruck der Ratte (1977) (1)
Effect of beta-adrenoceptor blockade on the cardiovascular and hyperglycaemic actions of diazoxide (1978) (1)
Molekularmedizinische Grundlagen von hereditären Tumorerkrankungen (2001) (1)
Monogen bedingte Erbkrankheiten 2 (2000) (1)
Bewusstsein, Selbstbewusstsein und humane Lebensform (2008) (1)
The Human Renin-Angiotensin-System in Transgenic Rats (1994) (1)
Assignment of the kinin receptor B1 and B2 genes (Bdkrb1 and Bdkrb2) to rat chromosome 6q3.2 by FISH and radiation hybrid mapping. (2000) (1)
Scientific Contributions j 3-Adrenergic Neuroeffector Mechanisms in Cardiac Hypertrophy of Renin Transgenic Rats (2005) (1)
Mapping genes for stroke: Genetic dissection of a rat model of complex human disease (1997) (1)
The renal kallikrein-kinin system in spontaneously hypertensive rats (1984) (1)
[Hypertension control. A community task of medicine]. (1982) (1)
Basis for the Treatment of Hypertension: Some Considerations Concerning the Epidemiology, Pathophysiology, Treatment, and Prevention of Hypertension (1990) (1)
Proceedings: Differential pressor responses to centrally administered angiotensin II (A II) in conscious rats, homozygous and heterozygous for hypothalamic diabetes insipidus. (1975) (1)
Electrolyte intake and blood pressure: A study in contradictions and controversy (1985) (1)
Transgenic Rats Deficient in Brain Angiotensinogen (2001) (1)
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]. (2020) (1)
Evidence that the hypertension-associated locus on rat chromosome 10, BP-SP1, is not identical with the angiotensin-converting enzyme gene locus (1994) (1)
Cell biology in hypertension (1991) (1)
Influence of Propranolol on the Central Effects of Angiotensin. (1978) (1)
Novel approaches towards the nuclear expression of ribozyme and antisense RNA genes in transgenic mice (1995) (1)
Contributions of animal models to understanding hypertension (1992) (1)
Hormonal Response to Acute Stress: Focus on Opioid Peptides (1984) (1)
Aspects on the Role of Neuropeptide Y and Atrial Peptides in Control of Vascular Resistance (1986) (1)
The Renin-Angiotensin System in Rats Made Hypertensive by Ligation of the Kidney Poles (1975) (1)
Neuroendocrine Aspects of Cardiovascular Control: The Brain Renin-Angiotensin System (1989) (1)
139. Characterization of the hypertensive transgenic rat: role of the adrenal gland (1991) (1)
Nomenclature of the renin-angiotensin system. Report of the Nomenclature Committee of the International Society of Hypertension (ISH) on the occasion of the 5th meeting of the ISH in Paris, June 12--14, 1978. (1978) (1)
Studies on the juxtaglomerular apparatus VI. Sympathetic innervation, catecholamines and the renin-angiotensin-system in rats and tree-shrews (Tupaia belangeri) (2004) (1)
5 Renin and Converting Enzyme are Localized Intracellularly in Nerve Endings of Rat Brain (1984) (1)
ALTERED CARDIOVASCULAR FUNCTIONALITY OF THE RENIN-ANGIOTENSIN SYSTEM AT THE ROSTRAL VENTROLATERAL MEDULLA OF TRANSGENIC RATS WITH LOW BRAIN ANGIOTENSINOGEN: P3.236 (2000) (1)
A013: Spironolactone increases survival in mREN2(27) transgenic rats with malignant hypertension (1998) (1)
[Primary hyperreninemia. An unusual cause of secondary arterial hypertension]. (2008) (1)
The renin and iso-renin-angiotensin system in rats with experimental pitutary tumors (38585). (1975) (1)
Differential actions of steroid hormones on the expression of the anipotensinogen gene expression (1990) (1)
Emotions and behavior : a systems approach (1989) (1)
Morphological and Biochemical Studies on Neuropeptide Y (NPY) and Adrenergic Mechanisms and their Interactions in Central Cardiovascular Regulation (1986) (1)
Genetics in arterial hypertension--clinical and experimental aspects. (1995) (1)
81. Requirements for expression of the angiotensin gene in tissue cell and transgenic animals (1991) (1)
A012 Reduction of neointima in transgenic (mRen2)27 hypertensive rats is augmented by dual lisinopril/losartan administration (1998) (1)
Renal and Mesenteric Arterial Tone in Rats with Human Renin and Angiotensinogen Genes (2000) (1)
[Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)]. (1986) (1)
[Development of a model of human renin hypertension in rats]. (1996) (1)
45 Influence of Denervation on the Content of Encephalin in the Adrenal Gland of Spontaneously Hypertensive Rats (1984) (1)
CORRECT EXPRESSION OF THE TRANSGENE IN THE BRAIN OF HYPERTENSIVE TRANSGENIC MICE CARRYING THE RAT ANGIOTENSINOGEN GENE (1992) (1)
Angiotensin Receptor Density and Messenger RNA Levels in Brain Medulla of (mRen2)27 and (ASrAogen) Transgenic Rats During Aging (2004) (1)
Alterations of Central Vasopressinergic System in Transgenic Rats with Low Brain Angiotensinogen (2000) (1)
[From genomics to public health]. (2013) (1)
Effects of angiotensin II and of an angiotensin II receptor antagonist on Simian virus 40-induced tumor growth in vivo (1980) (1)
Nomenclature of experimental renal hypertension. Report of the Nomenclature Committee of the International Society of Hypertension. (1978) (1)
Effect of Adrenal Arterial Infusion of Different Mg2+ Concentrations on the Spontaneous Release of Catecholamines in the Anesthetized Dog 1 (1973) (1)
Role of Central Mechanisms in the Blood Pressure Regulation (1982) (1)
Plasmaspiegel von Opioid-Peptiden im traumatisch-hämorrhagischen Schock beim Hund (1982) (1)
A New Transgenic Approach to an Old Problem (1999) (1)
VASCULAR ANGIOTENSIN (ANG) FORMATION IN RATS HARBORING THE REN-2 TRANSGENE (1991) (1)
Mitteilung als Funktion des Bewusstseins. Eine experimentelle Überlegung (2008) (1)
Erhöhte Reninausscheidung im Urin der ischämischen Niere bei experimenteller einseitiger Nierenarterienstenose des Hundes (1970) (1)
Transgenics of the RAS (2004) (1)
Plasma levels of opioid peptides and naloxone effects in canine hemorrhagic shock (1982) (1)
Urinary renin and norepinephrine excretion in dogs after unilateral renal artery constriction (1971) (1)
„Ecce homo!“ Seht, was ist der Mensch! (2008) (1)
Phänomenales Bewusstsein und Subjekte von Erfahrung (2008) (1)
The evolution of evolutionary molecular medicine (2012) (0)
A Free and Goodness-Oriented Living Being (2008) (0)
[Increased urinary renin excretion of ischemic kidneys in experimental unilateral stenoses of renal arteries in dogs]. (1970) (0)
Alterations in blood pressure control and cardiac pathophysiology in human tissue kallikrein transgenic fats (1998) (0)
Norm-Bound Animals (2008) (0)
[Some new aspects of the renin-angiotensin system]. (1973) (0)
What Are We Controlling For Anyway? (2005) (0)
Establishment of transgenic animals bearing additional genes of the renin angiotensin system (1990) (0)
The Role of Arginine-Vasopressin in Blood Pressure Control (1983) (0)
Genetic Rat Models for Hypertension (2005) (0)
Transgenic models of cardiac disease-focus on the renin-angiotensin system (1992) (0)
The World Hypertension League: goals and perspectives. (1995) (0)
Map of the Laboratory Rat A High-Density Integrated Genetic Linkage and Radiation Hybrid (1999) (0)
[Molecular genetics in arterial hypertension]. (1992) (0)
[Importance of extrarenal renin systems in the pathogenesis of arterial hypertension]. (1991) (0)
Baroreceptor Reflex Regulation in Anesthetized Older Transgenic Rats with Low Brain Angiotensinogen: Role of Endogenous Angiotensin II and Angiotensin‐(1‐7) (2007) (0)
JMM, past and present (2001) (0)
National Goals—Program‐oriented Interdisciplinary Research (2007) (0)
receptors in transgenic rats TGR(ASrAOGEN) Glial angiotensinogen regulates brain angiotensin II (2016) (0)
[The central nervous system, regulation of blood pressure and hypertension. Recent advances in the role of the central nervous system in the regulation of blood pressure]. (1984) (0)
Online First publication (1999) (0)
THE ROLE OF ENKEPHALINS IN BLOOD PRESSURE IN THE BRAIN (1981) (0)
Leenen Transgenic Rats Deficient in Brain Angiotensinogen Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in (2004) (0)
The development of hypertension in transgenic rats, TGR (mREN2)27 (2020) (0)
Genetics of hypertension (1995) (0)
Brain angiotensins in the cardiovascular regulation: usefulness of transgenic animals (1997) (0)
Regulation of atrial natriuretic peptide (ANP) secretion (1986) (0)
Primary hypertension in Germany: Epidemiology and treatment (1992) (0)
RENIN INCREASES BLOOD-PRESSURE (1979) (0)
Isolation and in Vivo Activity of Brain Renin from Mice and Men (1982) (0)
Decreased renal haemodynamic response to inhibition of nitric oxide synthase in subtotally nephrectomized rats (1995) (0)
Cardiac Protective Effect of Aldosterone Blockade Is Mediated Through Ap-1 and Nf-κB Suppression in Angiotensin Ii-Induced Cardiac Damage (2000) (0)
A New Strain of Hypertensive Rats with a Genetic Defect for Vasopressin Synthesis (2005) (0)
man is full of divine possibilities (2008) (0)
Defective suppression of aldosterone biosynthesis during stroke permissive diet in the stroke-prone SHR (1999) (0)
[Genes and hypertension. Genetic analysis instead of fasting?]. (1990) (0)
Increased cardiac angiotensin converting enzyme expression in genetically hypertensive rats (1992) (0)
Table of Contents (1992) (0)
[Salt or no salt? Contradictory theses on the role of cooking salt in the origin and prolongation of hypertension]. (1985) (0)
Endothelin and Experimental Hypertension (1995) (0)
Nomenclature of the renin-angiotensin system. (1978) (0)
Round table 1. Do transgenic techniques help us to understand hypertension? (1993) (0)
207 Tissue-specificity of human renin gene regulation in transgenic rats [(hRen)1936] by quinapril and sodium depletion (1993) (0)
Subject Index Vol. 51, 1990 (1990) (0)
TRANSGENIC RATS WITH HUMAN RENIN OR ANGIOTENSINOGEN GENE (1992) (0)
Molecular and cellular biology of the cardiac renin-angiotensin system (1992) (0)
[A simple sensitive micromethod for measurement of human plasma renin concentration]. (1972) (0)
[Pathophysiology of essential hypertension. Recent findings (author's transl)]. (1981) (0)
87. High sensitivity to angiotensin converting enzyme inhibition in hypertensive transgenic rats carrying the renin gene of the mouse (1991) (0)
Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. (1998) (0)
[Diagnosis and therapy of mild hypertension]. (1983) (0)
Cosegregation of stroke with altered endothelium-dependent vasorelaxation in the stroke-prone phenotype of spontaneously hypertensive rats. (1996) (0)
Nomenclature of Experimental Hypertension (1982) (0)
Progress in molecular medicine. From experimental genetics to the treatment of hypertensive patients. (1993) (0)
JMM, past and present (2001) (0)
The renin-angiotensin system. Advances in experimental biology and medicine, vol. 130 Edited by J.A. Johnson and R.R. Anderson Plenum Press, New York and London, 1980. $45.00 (307 pp.) ISBN 0-306-40469-9 (1981) (0)
How to deal with scientific controversy? (2002) (0)
Molecular biology, endocrinology, and pharmacology of the cardiac renin-angiotensin system. (1990) (0)
Regulation adrenaler Aldosteronsekretion und adrenalen Renins in TGR(mREN2)27 (1993) (0)
Transgenic rats, the genome contain at least one human in their gen, which is involved in blood pressure regulation (1991) (0)
Aspirin Inhibits Renal I-κB Kinase Activity, Nf-κB and Protects Against Renal and Cardiac Damage in Rats with Human Renin and Angiotensinogen Genes (dTGR) (2000) (0)
Specific expression of connexin40 and connexin43 in normal and hypertensive rat hearts (1995) (0)
The renin-angiotensin system in rats made hypertensive by ligation of the kidney poles (38584). (1975) (0)
Genetic analysis of the endothelial-dependent impaired vasorelaxation in the stroke-prone spontaneously hypertensive rat: a candidate gene approach. (1999) (0)
[Dopamine in the kidney: a further natriuretic hormone?]. (1985) (0)
Contents, Vol. 51, 1990 (1990) (0)
Health is more than Medicine-G20 Insights (2018) (0)
Putative Central Effects of Urapidii and Prazosin in Conscious Spontaneously Hypertensive Rats (1985) (0)
Abnormalities of endothelium-dependent vasorelaxation in the stroke-prone phenotype of intercross SHRSP/SHR Rats (1995) (0)
Emergence and evolution of the renin–angiotensin–aldosterone system (2012) (0)
THE EGYPTIAN JOURNAL OF HYPERTENSION AND CARDIOVASCULAR RISK (2008) (0)
JMM, past and present (2000) (0)
186 Modulation of angiotensin messenger RNA expression by antisense RNA (1993) (0)
Functional evidence of cardiovascular pathophysiology in the TGR 27 transgenic rat (1999) (0)
Sympathetic Afferent Reflex and Sympathetic Activation in Renovascular Hypertensive 7) in the Rostral Ventrolateral Medulla Modulates Enhanced Cardiac (2015) (0)
JMM, past and present (2001) (0)
Is there a role for locally produced complement in renal disease (2000) (0)
Molecular structure of rat bradykinin B2 receptor gene (1995) (0)
Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. (1998) (0)
RECOMMENDATIONS FOR NOMENCLATURE OF THE RENIN-ANGIOTENSIN SYSTEM (1977) (0)
Aspects ofmolecular biology andbiochemistry ofthecardiac renin-angiotensi n system (1989) (0)
Dexamethasone Inhibits Nf-κB, P22phox, and Protects Against Angiotensin Ii-Induced Renal Damage (2000) (0)
Role of nNOS in Regulation of Renal Function 579 Experiment 1 : Studies on nNOS mRNA expression in the renal cortex (2003) (0)
TRANSGENIC RATS HARBORING THE HUMAN ANGIOTENSINOGEN GENE - SPECIES-SPECIFIC BLOOD-PRESSURE RESPONSE TO HUMAN RENIN INFUSION (1992) (0)
SEXUAL DIMORPHISM OF BLOOD-PRESSURE IN TRANSGENIC RATS TGR( MESSENGER REN2)27 HARBORING THE MURINE REN-2 GENE (1992) (0)
JMM, past and present. Meningitis cerebro-spinalis epidemica. (2001) (0)
CARDIOVASCULAR REGULATION IN THE CbCHLORALOSE ANAESTHETIZED RAT. (1985) (0)
ACE and the Vascular Wall - from Genotype to Therapy: Roche Satellite Symposium, 12th World Congress of Cardiology, Berlin, September 1994 (1995) (0)
An “Indian” Perspective (2008) (0)
Renin Gene Expression and Hypertension in Transgenic Animals (2018) (0)
15 Shift of myosin isoenzyme pattern and decreased myosin phosphorylation may explain decreased cardiac function in chronic hypertension (1988) (0)
Regulation Angiotensinogen Concentrations and Renin Clearance : Implications for Blood Pressure (2000) (0)
["Hypertension 2008"]. (2008) (0)
The Renin-Angiotensin System in the Brain1 (1987) (0)
Friedrich Cameron Luft turns 60: bridging the New and the Old World (2002) (0)
[Organization of the National Blood Pressure Program (NBP). Prevention by treatment of risk factors]. (1985) (0)
An old couple: the renin–angiotensin system (RAS) and the Journal of Molecular Medicine (JMolMed) (2008) (0)
Subject Index Vol. 2, 1991 (2004) (0)
Hormones, autacoids, neurotransmitters and growth factors. (1998) (0)
JMM, past and present (2001) (0)
Effect of AP III in Glomerular Disease (1986) (0)
P2-039 Initial characterization of a transgenic rat model of Alzheimer's disease (2004) (0)
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION: P2.168 (2000) (0)
Spironolactone Ameliorates Angiotensin Ii-Induced Renal Damage Via the Inhibition of Ap-1 and Nf-κB (2000) (0)
Comment on “the prickly pear” (2000) (0)
Alterations in Blood Pressure and Heart Rate Variabililty in Transgenic Rats with Low Brain Angiotensinogen (2000) (0)
Reactivity to endothelin-1 of aortic strips from transgenic hypertensive rats TGR (mRen 2) 27 (1995) (0)
JMM, past and present. On dysmenorrhea due to mechanical causes, 1865. (2001) (0)
Hypertension Summer School 1992 (1993) (0)
147 Reduced expression of the sarcolemmal calcium pump ??? a novel abnormality in hypertensive cardiac hypertrophy (1993) (0)
What is a Human Being (2008) (0)
Demonstration ofrenin mRNA,angiotensinogen mRNA,andangiotensin converting enzyme mRNA expression inthehumaneye: evidence for anintraocular renin-angiotensi (1996) (0)
[Renin activity in the plasma, urine and adrenal cortex of dogs in various physiopathologic conditions]. (1971) (0)
JMM, past and present (2000) (0)
Tissue concentrations of opioid peptides in rats do not depend on blood pressure height. (1984) (0)
Partnership for Sustainable Health Development in Uncertain Situations. (2019) (0)
[Variable action of central and peripheral angiotensin II blockade in genetic hypertension in rats]. (1977) (0)
What is the World Health Summit for? (2014) (0)
Impaired Baroreceptor Reflex Function of Older ASrAOGEN Rats (2006) (0)
9 Androgen-dependent regulation of blood pressure and renin/angiotensin messenger RNA expression in hypertensive transgenic (mRen2)27 rats (1993) (0)
JMM, past and present (2001) (0)
Pressor Responses to Central Sodium and Ouabain Are Attenuated in Transgenic Rats Deficient in Brain Angiotensinogen (2000) (0)
JMM, past and present (2001) (0)
Symposium: Renin-angiotensin-aldosterone system and hypertension. (1978) (0)
JMM, past and present (2001) (0)
REN-2 transgenic model of hypertension (1995) (0)
Intracellular Signals Regulating Atrial Natriuretic Peptide (ANP) Secretion (1986) (0)
[Brain peptides and the regulation of blood pressure]. (1983) (0)
Highblood pressureintransgenic micecarrying therat angiotensinogen gene (1992) (0)
Echocardiographic Evaluation of the TGR(mRen2)27 Transgenic Rat Reveals Severe Ventricular Hypertrophy and Pericardial Effusion (1999) (0)
Hypertension control: world wide experience. Proceedings of the World Conference on Hypertension Control. Ottawa, Canada, 21-24 June 1995. (1996) (0)
Transgenic Rats Harboring Human Renin and Angiotensinogen Genes Induced End-Organ Damage in Double − Cyclosporin (2000) (0)
The Role of Baroreceptor Reflex Activation in the Responses Following Centrally Administered Angiotensin II (1985) (0)
The importance of animal models for hypertension research (1990) (0)
[Hemodynamics and excretory function of the kidney during furosemide and diazoxide administration. A contribution to the regulation of renin activity]. (1971) (0)
Pharmacokinetic and pharmacodynamic studies of infusions with [Sar1, Val5, Ala8] angiotensin II (saralasin) (2005) (0)
[Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium]. (1985) (0)
[Not all salt is salt]. (1987) (0)
[Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats]. (1988) (0)
Die Hypertonie als ständige Herausforderung unserer Zeit (1984) (0)
Fühlen, Sprache und Sozialität (2008) (0)
Bewusstsein als Korrektiv (2008) (0)
Über das Menschsein (2008) (0)
Schade, dass ein Buchstabe fehlt … (2008) (0)
Volkskrankheit Bluthochdruck: Molekulargenetik gibt neue Einblicke (2001) (0)
Die Entdeckung des „Social Brain“ (2008) (0)
Historischer Überblick: Beiträge von Chemie, Biochemie, Molekulargenetik und Molekularbiologie zur Entwicklung der Molekularen Medizin1 (1997) (0)
Grundsätze und Thesen zur Zusammenarbeit zwischen Hochschule und Wirtschaft (1992) (0)
Ziele und Aufbau des Nationalen Blutdruck-Programms (1987) (0)
Als Mensch den Menschen erkennen (2008) (0)
Plasmaspiegel von Opioid-Peptiden und Nalaxonwirkung im traumatisch-hämorrhagischen Schock beim Hund (1983) (0)
Menschsein bis zur Kenntlichkeit entstellt (2008) (0)
ACE-Hemmung als therapeutisches Prinzip (1991) (0)
Das Tier, das aus sich selber etwas macht (2008) (0)
Selbstbewusste Endlichkeit im Raum der Gründe (2008) (0)
Mechanismus der Gewebe-Angiotensin-II-Bildung im Herzen und neue Befunde zum kardialen Angiotensin-II-System (1996) (0)
Ein holistisches Gesundheitskonzept: Die Evolutionäre Medizin (2021) (0)
Von Kartoffeln und Menschen (2008) (0)
Identifizierung von Risikofaktoren: Pathophysiologische Beobachtungen (1982) (0)
Das Tier, das seine Grenzen erkenntund sich nicht daran halten will (2008) (0)
Begabt zur Freiheit – stets auf dem Wege, sie zu erringen, ständig in Gefahr, sie zu verlieren (2008) (0)
Tagesform, oder: Wir persönlich (2008) (0)
Entsalzen oder Pökeln? (1985) (0)
Salz ist nicht gleich Salz (2009) (0)
Subjekte sind Artefakte. Aber das macht nichts. (2008) (0)
Gedanken zu haben (2008) (0)
Das Gehirn Renin-Angiotensin System: Ein Modell für die Synthese von Peptiden im Gehirn (1980) (0)
Der Mensch ist zu allem fähig (2008) (0)
Bewusstsein und Freiheit (2008) (0)
Der Mensch ist mehr als die Summe seiner Gene (2008) (0)
Einige Bemerkungen zum Menschsein des Menschen aus theologischer Perspektive (2008) (0)
Eine diskriminierende Frage – mit der logischen Folge der Integration (2008) (0)
Die Natur des Menschen und die Naturwissenschaften (2008) (0)
Funktionen des Bewusstseins in sozialen Systemen (2008) (0)
Einleitung: Reflexionen über den Gesundheitsbegriff in seinem Kontext (2021) (0)
Sprache, Musik und Mathematik (2008) (0)
Wähle eine Benennung (2008) (0)
Der Mensch ist reflexive Kontingenz (2008) (0)
Die Größe des Menschen (2008) (0)
Editor’s Note (1999) (0)
Der Mensch ist Mitmensch (2008) (0)
Der Mensch im Qur’an (2008) (0)
Nephrologie und Global Health? Ein Zwischenbericht über den Aufbau von Patientenversorgung im ländlichen Uganda (2021) (0)
151 years Berliner Klinische Wochenschrift and the 20th anniversary of the Journal of Molecular Medicine (2015) (0)
Genetisches Wissen fr Gesundheit und Krankheit (2000) (0)
Ganz Tier und ganz Kulturwesen (2008) (0)
Das Renin-Angiotensin-System, Molekularbiologie und Pharmakologie — Was gibt es Neues? (1990) (0)
Die anthropologische als normativ-ethische Frage (2008) (0)
Ja, er kann. Islam als empowerment (2008) (0)
Herz-Kreislauf-Erkrankungen (1998) (0)
Was latent geblieben war (2008) (0)
Konferenz der Akademien der Wissenschaften der Bundesrepublik Deutschland. Wissenschaft -Wirtschaft -Öffentlichkeit (1992) (0)
Der Mensch ist nur Mensch durch Sprache (2008) (0)
Bewusstsein und Gedächtnis: Die Bedeutung der Kohärenz und Konsistenz von Erinnerungen (2008) (0)
Ein kleines Ereignis zwischen Nichts und Nichts (2008) (0)
Bewusstsein als funktionales Element der natürlichen Welt (2008) (0)
Der Mensch oder die Menschen (2008) (0)
Die Funktion des religiösen Bewusstseins in der Frage des Menschen nach sich selbst (2008) (0)
Der Mensch zwischen Ost und West (2008) (0)
Bedeutung der Opiatpeptide für die Blutdruckregulation (1983) (0)
Der Mensch – ein animal emotionale (2008) (0)
Zum Menschenbild im Buddhismus (2008) (0)
Was ist der Mensch (2008) (0)
Die funktionale Rolle des Bewusstseins: Integration, Isomorphie und Emergenz (2008) (0)
Ein eigenartiges Tier (2008) (0)
Der Mensch kann (2008) (0)
Von der Ambivalenz des Naturphänomens Bewusstsein als Möglichkeit und Gefängnis (2008) (0)
Eine unbekannte Spezies (2008) (0)
Was ist der Mensch? Eine wahre Geschichte. (2008) (0)
Nomaden im Zweistromland (2008) (0)
Berlin — Stadt des Wissens? Deutschland braucht einen erlebbaren Ort der neuen humanen Wissensgesellschaft (2003) (0)
Neun nachdenkliche Bemerkungen zur Frage: Was ist der Mensch? (2008) (0)
Affektprogramme und Gefühle (2008) (0)
Deutsche Pharmakologische Gesellschaft (2004) (0)
Der Mensch im Blick des anderen Menschen (2008) (0)
Die Idee des Humanen (2021) (0)
Das, was nicht sein soll (2008) (0)
Bluthochdruck und Organschäden: Die besondere Rolle des hormonalen und vaskulären Renin-Angiotensin-Systems (1991) (0)
Gesundheit aus Sicht der Patientinnen und Patienten (2021) (0)
Zur Frage nach dem Wesen des Menschen aus theologischer Sicht (2008) (0)
ISOLIERTE SYSTOLISCHE HYPERTONIE IM ALTER (2008) (0)
Forschungsreise zu sich selbst (2008) (0)
Nachdenken über Menschen (2008) (0)
Bewusstsein – Reichweite und Grenzen naturwissenschaftlicher Erklärung (2008) (0)
Mit der Individualität verliert sich die Menschlichkeit (2008) (0)
Genetisches Wissen fuer Gesundheit und Krankheit [Genetic knowledge for health and disease] (2000) (0)
Es bleibt bei dem Fragezeichen (2008) (0)
Funktion und Bewusstsein (2008) (0)
Was ist der Mensch? Für ein Boot über den Rubikon (2008) (0)
Was ist der Mensch? In vieler Hinsicht sich selbst ein Rätsel … (2008) (0)
Was für eine Frage (2008) (0)
Genetische Analyse des Bluthochdrucks (1995) (0)
Symbolkombinatorik als Gattungsmerkmal (2008) (0)
Perspectives on Research in Emotional Stress (2022) (0)
Evolutionary molecular medicine (2012) (0)
Contents Vol. 2, 1991 (1991) (0)

This paper list is powered by the following services:

Other Resources About Detlev Ganten

en.wikipedia.org

What Schools Are Affiliated With Detlev Ganten?

Detlev Ganten is affiliated with the following schools:

Detlev Ganten's Academic­Influence.com Rankings